Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 171

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Results From a Prospective, International, Epidemiologic Study of Invasive Candidiasis in Children and Neonates

Steinbach, William J., Roilides, Emmanuel, Berman, David, Hoffman, Jill A., Groll, Andreas H., Bin-Hussain, Ibrahim, Palazzi, Debra L., Castagnola, Elio, Halasa, Natasha, Velegraki, Aristea, Dvorak, Christopher C., Charkabarti, Arunaloke, Sung, Lillian, Danziger-Isakov, Lara, Lachenauer, Catherine, Arrieta, Antonio, Knapp, Katherine, Abzug, Mark J., Ziebold, Christine, Lehrnbecher, Thomas, Klingspor, Lena, Warris, Adilia, Leckerman, Kateri, Martling, Teresa, Walsh, Thomas J., Benjamin, Daniel K., Zaoutis, Theoklis E. · 2012 · Pediatric Infectious Disease Journal

Abstract

BACKGROUND: Candida species are the third most common cause of pediatric health care-associated bloodstream infection in the United States and Europe. To our knowledge, this report from the International Pediatric Fungal Network is the largest prospective, multicenter observational study dedicated to pediatric and neonatal invasive candidiasis. METHODS: From 2007 to 2011, we enrolled 196 pediatric and 25 neonatal patients with invasive candidiasis. RESULTS: Non-albicans Candida species predominated in pediatric (56%) and neonatal (52%) age groups, yet Candida albicans was the most common species in both groups. Successful treatment responses were observed in pediatric (76%) and neonatal patients (92%). Infection with Candida parapsilosis led to successful responses in pediatric (92%) and neonatal (100%) patients, whereas infection with Candida glabrata was associated with a lower successful outcome in pediatric patients (55%). The most commonly used primary antifungal therapies for pediatric invasive candidiasis were fluconazole (21%), liposomal amphotericin B (20%) and micafungin (18%). Outcome of pediatric invasive candidiasis was similar in response to polyenes (73%), triazoles (67%) and echinocandins (73%). The most commonly used primary antifungal therapies for neonatal invasive candidiasis were fluconazole (32%), caspofungin (24%) and liposomal amphotericin B (16%) and micafungin (8%). Outcomes of neonatal candidiasis by antifungal class again revealed similar response rates among the classes. CONCLUSIONS: We found a predominance of non-albicans Candida infection in children and similar outcomes based on antifungal class used. This international collaborative study sets the foundation for large epidemiologic studies focusing on the unique features of neonatal and pediatric candidiasis and comparative studies of therapeutic interventions in these populations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/inf.0b013e3182737427

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 171

Metadata

Authors
Steinbach, W. J., Roilides, E., Berman, D., Hoffman, J. A., Groll, A. H., Bin-Hussain, I., Palazzi, D. L., Castagnola, E., Halasa, N., Velegraki, A., Dvorak, C. C., Charkabarti, A., Sung, L., Danziger-Isakov, L., Lachenauer, C., Arrieta, A., Knapp, K., Abzug, M. J., Ziebold, C., Lehrnbecher, T., Klingspor, L., Warris, A., Leckerman, K., Martling, T., Walsh, T. J., Benjamin, D. K., & Zaoutis, T. E.
Venue
Pediatric Infectious Disease Journal
Published
2012-12
Volume
31
Issue
12
Pages
1252-1257
ISSN
0891-3668 (ISSN-L)
OpenAlex
W2117142796
Cited by
171
References
4
FWCI
8.70
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Results From a Prospective, International, Epidemiologic Study of Invasive Candidiasis in Children and Neonates. https://app.cochat.ai/papers/10.1097/inf.0b013e3182737427
The paper
Steinbach, W. J., Roilides, E., Berman, D., Hoffman, J. A., Groll, A. H., Bin-Hussain, I., Palazzi, D. L., Castagnola, E., Halasa, N., Velegraki, A., Dvorak, C. C., Charkabarti, A., Sung, L., Danziger-Isakov, L., Lachenauer, C., Arrieta, A., Knapp, K., Abzug, M. J., Ziebold, C., . . . Zaoutis, T. E. (2012). Results From a Prospective, International, Epidemiologic Study of Invasive Candidiasis in Children and Neonates. Pediatric Infectious Disease Journal. https://doi.org/10.1097/inf.0b013e3182737427

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.